Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0010200 (
cough
)
23,843
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Pulmonary dysfunction is a common complication of head trauma and spinal cord injury. Abnormal breathing patterns reflect the influence of altered neural integration. Early arterial hypoxemia can result from ventilation-perfusion mismatching, microatelectasis, aspiration,
fat embolism
, or the development of the adult respiratory distress syndrome. Significant changes in lung volumes, ventilation, and gas exchange can occur in spinal cord injury as a result of the loss of diaphramatic or intercostal muscle function. Recruitment of accessory respiratory muscles plays an important role in stabilizing the rib cage and improving expiratory function. Strength training improves expiratory muscle function in quadriplegics and should be continued indefinitely. Most importantly, survival of patients with CNS injuries improves with meticulous and vigorous pulmonary hygiene. The pulmonary hygiene program should include regular changes in the patient's position, assisted
coughing
and deep breathing exercises, incentive spirometer, bronchodilators, fiberoptic bronchoscopy when indicated, and frequent monitoring of pulmonary mechanics. Long-term survival of the patient with head trauma or spinal cord injury is correlated to successful weaning from mechanical ventilation. Various forms of mechanical ventilator support can be adopted for the patient's ventilatory needs, and many patients will achieve some degree of freedom from mechanical ventilation. Newer ventilatory assist devices that do not require tracheostomy should be considered.
...
PMID:Respiratory dysfunction associated with traumatic injury to the central nervous system. 786 88
A 67-year-old man with a four-year history of mixed connective tissue disease (MCTD) associated with interstitial pneumonia was admitted to our hospital with a complaint of dyspnea and moist
cough
. Because the interstitial pneumonia was exacerbated, he was given high-dose steroid treatment (pulse therapy and sequential oral treatment of PSL 50 mg/day). After treatment his general condition showed some improvement, but then he suddenly died of acute respiratory failure. Autopsy disclosed fat emboli in the lungs, kidneys, liver and myocardium. The
fat embolism
may have been a consequence of the steroid treatment.
Fat embolism
should be taken into account as one of the causes of the acute respiratory failure in collagen vascular disease patients receiving steroid treatment.
...
PMID:[A case of systemic fat embolism in mixed connective tissue disease associated with interstitial pneumonia during steroid treatment]. 1157 27
Liquid silicone is an inert material that is utilized for cosmetic procedures by physicians as well as illegally by nonmedical personnel. We present a case report and collated clinical findings of 32 other patients who were hospitalized after illegal silicone injections. Symptoms and signs of the "silicone syndrome" included dyspnea, fever,
cough
, hemoptysis, chest pain, hypoxia, alveolar hemorrhage, and altered consciousness. Bilateral patchy alveolar infiltrates were present on the chest radiographs, and silicone pulmonary emboli were detected in all the patients. The patients could be divided into two groups based on the initial presentation and clinical outcome. Twenty-seven patients in group 1 presented predominantly with respiratory symptoms, and 93% of patients were discharged home within 3 weeks. Six patients (group 2) presented with severe neurologic findings, and experienced rapid deterioration and 100% mortality. The clinical findings after silicone embolism are very similar to the published reports of
fat embolism
, including hypoxemia in 92% of patients with silicone embolism (patients with
fat embolism
, 56 to 96%), dyspnea in 88% of patients (patients with
fat embolism
, 56 to 75%), fever in 70% of patients (patients with
fat embolism
, 23 to 67%), alveolar hemorrhage in 64% of patients (patients with
fat embolism
, 66%), neurologic symptoms in 33% of patients (patients with
fat embolism
, 22 to 86%), petechiae in 18% of patients (patients with
fat embolism
, 20 to 50%), chest pain in 15% of patients (patients with
fat embolism
, 26%), and mortality in 24% of patients (patients with
fat embolism
, 5 to 20%). The similarities among the mode of injury to the lung, the clinical findings, and the high incidence of alveolar hemorrhage suggest a common pathogenesis of silicone and
fat embolism
syndromes. We discuss the possibility that the activation of the coagulation system may be important in the development of these clinical syndromes.
...
PMID:Silicone embolism syndrome: a case report, review of the literature, and comparison with fat embolism syndrome. 1594 50
Bone marrow
fat embolism
usually occurs following multiple bone fractures, intraosseous surgical procedures, following vigorous cardiac resuscitation, ecclampsia, sickle cell anemia, malignancies, etc. We present a case of 70-year-old male who presented with fever,
cough
with expectoration, respiratory distress, altered sensorium, hypotension and thrombocytopenia, and diagnosed to have dengue shock syndrome and expired within 1 day of admission. Postmortem lung biopsy revealed bone marrow
fat embolism
.
...
PMID:A fatal case of bone marrow embolism of unknown cause masquerading clinically as dengue shock syndrome. 2345 11